| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |